Search All News
In animal studies, warfarin, a widely used blood thinner, shrinks tumors by promoting a self-destruct mechanism in cancer cells.
Columbia cancer researchers have discovered how melanoma can hide from our immune system, pointing to ways drug developers might restore the tumor’s vulnerability.
The Irving Institute for Clinical and Translational Research announced four new Herbert and Florence Irving Scholars for the 2023-2026 cohort.
- April 14, 2023
Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
- February 23, 2023
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
- December 13, 2022
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
- November 30, 2022
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
- November 28, 2022
Bad weather forced the cancellation of the in-person cycling fundraiser, but participants organized their own bike rides and raised $1.1 million for cancer research and patient care at Columbia.
- November 16, 2022
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.